1
|
dos Santos AC, Nogueira ML, de Oliveira FP, Costa EV, Bezerra DP. Essential Oils of Duguetia Species A. St. Hill (Annonaceae): Chemical Diversity and Pharmacological Potential. Biomolecules 2022; 12:biom12050615. [PMID: 35625543 PMCID: PMC9138787 DOI: 10.3390/biom12050615] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2022] [Revised: 04/13/2022] [Accepted: 04/18/2022] [Indexed: 01/27/2023] Open
Abstract
Duguetia A. St. Hill (Annonaceae) is recognized as one of the major genera with approximately 100 species, 67 of which are found in Brazil (29 of those are endemic). They are arboreal species with edible fruits known as “pindaíba”, “pindaíva” “pinha”, and “envira” in Brazil. Many Duguetia species, in particular, have been used in traditional medicine to treat renal colic, stomachache, rheumatism, cough, toothache, muscle pain, fever, gastrointestinal pain, and breathing difficulties. In this study, we reviewed the chemical constituents and pharmacological properties of essential oils (EOs) from Duguetia species. A total of 12 species were found, along with their EO chemical constituents and bioactivities. Bicyclogermacrene, humulene epoxide II, spathulenol, germacrene D, caryophyllene oxide, viridiflorene, α-pinene, β-caryophyllene, and β-pinene were the main chemical constituents reported. The pharmacological effects of Duguetia species EOs included anti-inflammatory, antinociceptive, antibacterial, antifungal, antioxidant, anti-trypanosoma, cytotoxic and antitumor properties. This information adds to our understanding of the potential of the EOs of Duguetia species.
Collapse
Affiliation(s)
- Albert C. dos Santos
- Department of Chemistry, Federal University of Amazonas (UFAM), Manaus 69080-900, AM, Brazil;
| | - Mateus L. Nogueira
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador 40296-710, BA, Brazil; (M.L.N.); (F.P.d.O.)
| | - Felipe P. de Oliveira
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador 40296-710, BA, Brazil; (M.L.N.); (F.P.d.O.)
| | - Emmanoel V. Costa
- Department of Chemistry, Federal University of Amazonas (UFAM), Manaus 69080-900, AM, Brazil;
- Correspondence: (E.V.C.); (D.P.B.); Tel./Fax: +55-92-3305-1181 (ext. 2870) (E.V.C.); +55-71-3176-2272 (D.P.B.)
| | - Daniel P. Bezerra
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador 40296-710, BA, Brazil; (M.L.N.); (F.P.d.O.)
- Correspondence: (E.V.C.); (D.P.B.); Tel./Fax: +55-92-3305-1181 (ext. 2870) (E.V.C.); +55-71-3176-2272 (D.P.B.)
| |
Collapse
|
2
|
de Oliveira FP, da C Rodrigues ACB, de Lima EJSP, Silva VR, de S Santos L, da Anunciação TA, Nogueira ML, Soares MBP, Dias RB, Gurgel Rocha CA, Duvoisin Junior S, Albuquerque PM, Lima ES, Gonçalves JFC, Bataglion GA, Costa EV, da Silva FMA, Koolen HHF, Bezerra DP. Essential Oil from Bark of Aniba parviflora (Meisn.) Mez (Lauraceae) Reduces HepG2 Cell Proliferation and Inhibits Tumor Development in a Xenograft Model. Chem Biodivers 2021; 18:e2000938. [PMID: 33508178 DOI: 10.1002/cbdv.202000938] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2020] [Accepted: 01/28/2021] [Indexed: 11/11/2022]
Abstract
Aniba parviflora (Meisn.) Mez (Lauraceae) is an aromatic plant of the Amazon rainforest, which has a tremendous commercial value in the perfumery industry; it is popularly used as flavoring sachets and aromatic baths. In Brazilian folk medicine, A. parviflora is used to treat victims of snakebites. Herein, we analyzed the chemical composition of A. parviflora bark essential oil (EO) and its effect on the growth of human hepatocellular carcinoma HepG2 cells in vitro and in vivo. EO was obtained by hydrodistillation and characterized by GC-MS and GC-FID. The main constituents of EO were linalool (16.3±3.15), α-humulene (14.5±2.41 %), δ-cadinene (10.2±1.09 %), α-copaene (9.51±1.12 %) and germacrene B (7.58±2.15 %). Initially, EO's cytotoxic effect was evaluated against five cancer cell lines (HepG2, MCF-7, HCT116, HL-60 and B16-F10) and one non-cancerous one (MRC-5), using the Alamar blue method after 72 h of treatment. The calculated IC50 values were 9.05, 22.04, >50, 15.36, 17.57, and 30.46 μg/mL, respectively. The best selectivity was for HepG2 cells with a selective index of 3.4. DNA Fragmentation and cell cycle distribution were quantified in HepG2 cells by flow cytometry after a treatment period of 24 and 48 h. The effect of EO on tumor development in vivo was evaluated in a xenograft model using C.B-17 SCID mice engrafted with HepG2 cells. In vivo tumor growth inhibition of HepG2 xenograft at the doses of 40 and 80 mg/kg were 12.1 and 62.4 %, respectively.
Collapse
Affiliation(s)
- Felipe P de Oliveira
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710, Salvador, Bahia, Brazil or
| | | | - Emilly J S P de Lima
- Metabolomics and Mass Spectrometry Research Group, Amazonas State University (UEA), 690065-130, Manaus, Amazonas, Brazil or
| | - Valdenizia R Silva
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710, Salvador, Bahia, Brazil or
| | - Luciano de S Santos
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710, Salvador, Bahia, Brazil or
| | - Talita A da Anunciação
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710, Salvador, Bahia, Brazil or
| | - Mateus L Nogueira
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710, Salvador, Bahia, Brazil or
| | - Milena B P Soares
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710, Salvador, Bahia, Brazil or
| | - Rosane B Dias
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710, Salvador, Bahia, Brazil or.,School of Medicine and School of Dentistry, Federal University of Bahia, 40301-155, Salvador, Bahia, Brazil
| | - Clarissa A Gurgel Rocha
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710, Salvador, Bahia, Brazil or.,School of Medicine and School of Dentistry, Federal University of Bahia, 40301-155, Salvador, Bahia, Brazil
| | - Sérgio Duvoisin Junior
- Laboratory of Applied Chemistry and Technology, Amazonas State University (UEA), 69050-020, Manaus, Amazonas, Brazil
| | - Patrícia M Albuquerque
- Laboratory of Applied Chemistry and Technology, Amazonas State University (UEA), 69050-020, Manaus, Amazonas, Brazil
| | - Emerson S Lima
- Faculty of Pharmacy, Federal University of Amazonas (UFAM), 69077-000, Manaus, Amazonas, Brazil
| | - José F C Gonçalves
- Laboratory of Plant Physiology and Biochemistry, National Institute for Amazonian Research (INPA), 69011-970, Manaus, Amazonas, Brazil
| | - Giovana A Bataglion
- Department of Chemistry, Federal University of Amazonas (UFAM), 69080-900, Manaus, Amazonas, Brazil
| | - Emmanoel V Costa
- Department of Chemistry, Federal University of Amazonas (UFAM), 69080-900, Manaus, Amazonas, Brazil
| | - Felipe M A da Silva
- Analytical Center, Multidisciplinary Support Center (CAM), Federal University of Amazonas (UFAM), 69080-900, Manaus, Amazonas, Brazil
| | - Hector H F Koolen
- Metabolomics and Mass Spectrometry Research Group, Amazonas State University (UEA), 690065-130, Manaus, Amazonas, Brazil or
| | - Daniel P Bezerra
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710, Salvador, Bahia, Brazil or
| |
Collapse
|
3
|
Rodrigues ACBDC, Oliveira FPD, Dias RB, Sales CBS, Rocha CAG, Soares MBP, Costa EV, Silva FMAD, Rocha WC, Koolen HHF, Bezerra DP. In vitro and in vivo anti-leukemia activity of the stem bark of Salacia impressifolia (Miers) A. C. Smith (Celastraceae). J Ethnopharmacol 2019; 231:516-524. [PMID: 30445109 DOI: 10.1016/j.jep.2018.11.008] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/10/2018] [Revised: 10/18/2018] [Accepted: 11/03/2018] [Indexed: 06/09/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Salacia impressifolia (Miers) A. C. Smith (family Celastraceae) is a traditional medicinal plant found in the Amazon Rainforest known as "miraruíra", "cipó-miraruíra" or "panu" and is traditionally used to treat dengue, flu, inflammation, pain, diabetes, male impotency, renal affections, rheumatism and cancer. AIM OF THE STUDY The aim of this study was to investigate in vitro and in vivo anti-leukemia activity of the stem bark of S. impressifolia in experimental models. MATERIALS AND METHODS The in vitro cytotoxic activity of extracts, fractions and quinonemethide triterpenes (22-hydroxytingenone, tingenone and pristimerin) from the stem bark of S. impressifolia in cultured cancer cells was determined. The in vivo antitumor activity of the ethyl acetate extract (EAE) and of its fraction (FEAE.3) from the stem bark of S. impressifolia was assessed in C.B-17 severe combined immunodeficient (SCID) mice engrafted with human promyelocytic leukemia HL-60 cells. RESULTS The extract EAE, its fraction FEAE.3, and quinonemethide triterpenes exhibited potent cytotoxicity against cancer cell lines, including in vitro anti-leukemia activity against HL-60 and K-562 cells. Moreover, extract EAE and its fraction FEAE.3 inhibited the in vivo development of HL-60 cells engrafted in C.B-17 SCID mice. Tumor mass inhibition rates were measured as 40.4% and 81.5% for the extract EAE (20 mg/kg) and for its fraction FEAE.3 (20 mg/kg), respectively. CONCLUSIONS Ethyl acetate extract and its fraction from the stem bark of S. impressifolia exhibit in vitro and in vivo anti-leukemia activity that can be attributed to their quinonemethide triterpenes. These data confirm the ethnopharmacological use of this species and may contribute to the development of a novel anticancer herbal medicine.
Collapse
Affiliation(s)
| | - Felipe P de Oliveira
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Bahia 40296-710, Brazil
| | - Rosane B Dias
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Bahia 40296-710, Brazil
| | - Caroline B S Sales
- Department of Biomorphology, Institute of Health Sciences, Federal University of Bahia, Salvador (UFBA), Bahia 40110-902, Brazil
| | - Clarissa A G Rocha
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Bahia 40296-710, Brazil
| | - Milena B P Soares
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Bahia 40296-710, Brazil; Center of Biotechnology and Cell Therapy, Hospital São Rafael, Salvador, Bahia 41253-190, Brazil
| | - Emmanoel V Costa
- Department of Chemistry, Federal University of Amazonas (UFAM), Manaus, Amazonas 69077-000, Brazil
| | - Felipe M A da Silva
- Department of Chemistry, Federal University of Amazonas (UFAM), Manaus, Amazonas 69077-000, Brazil
| | - Waldireny C Rocha
- Health and Biotechnology Institute, Federal University of Amazonas (UFAM), Coari, Amazonas 69460-000, Brazil
| | - Hector H F Koolen
- Metabolomics and Mass Spectrometry Research Group, Amazonas State University (UEA), Manaus, Amazonas 690065-130, Brazil
| | - Daniel P Bezerra
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Bahia 40296-710, Brazil.
| |
Collapse
|